Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 1997

View Archived Issues

Company Profile: Inhale Therapeutic Systems

Immunological method for preventing ALL in children available for licensing

NIH seeks licensees for raf protein kinase therapeutics

Brain GABA-A receptor ligands prepared at Neurogen

Bristol-Myers Squibb develops new ET antagonists

Anticonvulsants with reduced side effects from RCT

VEGF inhibitors discovered by Zeneca

New renin inhibitor in preclinical testing at JT/Yoshitomi

Novartis claims new antiasthmatic agents

Inhibitors of viral neuraminidase from Biota

American Home Products reports compounds for atherosclerosis

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

BMS to sell Gea

Clinical results reported for Onco TCS

New guidelines for patients exposed to fenfluramine or dexfenfluramine

FACET study demonstrates improved asthma control with Pulmicort and Oxis

D-19575: new cytostatic drug without renal side effects

Anesta's Actiq denied FDA approval

Development of tolerance to OPC-31260 effects in rats after chronic treatment

Roche launches Fortovase in U.S.

P&G kicks off U.S. arm of ALIVE trial

S-Nitrosocaptopril exerts both acute and chronic hypotensive effects in rats

Roche resubmits NDA for Xenical

Results reported for Myriad's CardiaRisk

Cardioprotective activity of monoHER demonstrated in preclinical models

Celecoxib: safety and efficacy data presented at rheumatology meeting

Novartis submits BLA for Simulect in U.S.

Amylin Pharmaceuticals: Q3 1997 highlights

New antidepressant and cognition enhancer developed in Russia

Biomira and Intracel negotiate acquisition of certain Biomira assets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...